The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bjerkholt Eric since year 2005.
The trader's CIK number is 1197350.
At the time of this reporting, Bjerkholt Eric is the Chief Financial Officer of Aimmune Therapeutics, Inc. .
(stock ticker symbol AIMT).
See this page for all insider trading activities at Aimmune Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-05-12||AIMT||Aimmune Therapeutics, Inc.||Buy||5,000||19.84||99,210|
|2016-05-19||CORI||Corium International, Inc.||Buy||14,131||3.70||52,327|
|2016-05-18||CORI||Corium International, Inc.||Buy||10,369||3.56||36,861|
|2015-07-24||SNSS||Sunesis Pharmaceuticals Inc||Sale||6,358||3.46||21,992|
|2014-08-27||SNSS||Sunesis Pharmaceuticals Inc||Sale||10,000||8.00||80,000|
|2014-08-27||SNSS||Sunesis Pharmaceuticals Inc||Option Ex||10,000||1.74||17,400|
|2010-10-08||SNSS||Sunesis Pharmaceuticals Inc||Buy||100,000||.31||30,900|
|2010-06-30||SNSS||Sunesis Pharmaceuticals Inc||Buy||238,243||.28||65,516|
|2007-03-13||SNSS||Sunesis Pharmaceuticals Inc||Buy||3,000||4.30||12,900|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bjerkholt Eric (Chief Financial Officer of Aimmune Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.